SHL to feature Molly® 2.25 and Molly® C at the 2016 Pharmapack Europe
At this year’s Pharmapack Europe held at Paris Expo, Porte de Versailles in Paris, SHL will be featuring Molly® 2.25, the much talked-about high volume autoinjector, as well as Molly® C, a newly developed product related to connectivity.
The Molly® 2.25 is SHL’s first high volume autoinjector with its design based on the original 1ml Molly®; it was created to meet the increasing need for simple delivery of larger doses. With improved features, the preconfigured device will be extremely attractive to customers who are looking for top-quality products with quick development timelines and reduced costs.
Derived from SHL’s connectivity-based program—Alubena™—for drug delivery, the Molly® C is a disposable autoinjector with a reusable recording unit, which tracks and saves injection data. This concept was created to improve patient adherence, which has long been a problem in the healthcare industry. With Molly® “C”, which stands for “connected device”, injection data can be better managed and stored with an app that is available for demonstration at the SHL booth.
These two new products are indications that SHL is constantly keeping a focused and innovative approach to advanced drug delivery, developing products that reflect market needs.
Both Molly® 2.25 and Molly® C will be available for demonstration at the SHL booth in the upcoming Pharmapack event. For further details, please visit us at Booth 736, Hall 5.2.
